Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 28, 2014; 20(48): 18228-18239
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18228
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18228
Figure 3 Mice treated with mesenchymal stem cells presented macroscopic colon characteristics similar to healthy animals.
A: Colon length. DSS, DSS-Saline and DSS-MSC IP groups showed a colon length significantly lower than the Naive group; B: Colon weight. DSS-MSC IV group showed significant difference in colon weight compared to DSS group; C: Representative image showing the difference in length between the colons submitted to different treatments. bP < 0.01 vs Naive group; dP < 0.01 vs DSS group, n = 5 mice/group. DSS: Dextran sulfate sodium; MSC: Mesenchymal stem cell.
-
Citation: Gonçalves FDC, Schneider N, Pinto FO, Meyer FS, Visioli F, Pfaffenseller B, Lopez PLDC, Passos EP, Cirne-Lima EO, Meurer L, Paz AH. Intravenous
vs intraperitoneal mesenchymal stem cells administration: What is the best route for treating experimental colitis? World J Gastroenterol 2014; 20(48): 18228-18239 - URL: https://www.wjgnet.com/1007-9327/full/v20/i48/18228.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i48.18228